Curbing Rx opioids will have little effect on overdoses – comments from Stefan Kertesz on Twitter @StefanKertesz – Feb 2019
I previously posted about the study that just came out which estimates the future trajectory of the “opioid crisis” and finds little use for restricting legitimate prescriptions: Study: Limiting opioid Rx won’t reduce overdose deaths
1/With 3% of overdose deaths (9 of 269) in Jefferson Cty, Alabama due to prescription opioids, there is a limit to how many lives are going to be saved by extending the 7 year decline in Rx, as underscored in a new study by @LarochelleMarc https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2723405
2/the new @JAMANetworkOpen paper properly asssumed a reduction in nonmedical use of Rx opioids since that reduction is already happening. The first problem is that other factors such as what opioids people start with & lethality of the illicit market dominate death rates
3/we have found the “limits of prescription control” – my article with @AJ_Gordon in @AddictionJrnl is free online here https://onlinelibrary.wiley.com/doi/full/10.1111/add.14394
Previously posted: The Limits of Prescription Control.
Opioid Rx now 19% down from 2006. Time to embrace a better approach to addiction care and Rx risk mitigation.
4/It is not just that our Rx control regime has fallen short in saving lives, it has entailed tacit acceptance of neglect and harm to Americans who do receive opioids: now reported & condemned by many: @AmerMedicalAssn @hrw @FoxNews https://www.hrw.org/news/2018/12/18/us-fears-prescribing-hurt-chronic-pain-patients
Previously posted: Human Rights Watch Investigating U.S. Pain Treatment
5/I am happy to have co-authored a brand new consensus article on challenges in the implementation of the 2016 @CDCgov Guideline on Prescribing #opioids, including many who are not always seen as being on the same “side”. https://academic.oup.com/painmedicine/advance-article-abstract/doi/10.1093/pm/pny307/5301726
Previously posted: Problems with CDC Guideline Implementation